论文信息 - Isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma patients with high‐risk cytogenetics: IKEMA subgroup analysis - 字舞流文

Isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma patients with high‐risk cytogenetics: IKEMA subgroup analysis

A. Oriol | P. Moreau | T. Facon | L. Rosiñol | K. Yong | M. Cavo | T. Martin | I. Špička | S. Macé | G. Mikala | M. Yağcı | M. Risse | G. Asset | H. Velde | Youngil Koh | G. Martinez | A. Lim | Y. Koh | I. Spicka